INR 108.68
(-1.18%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 17.65 Billion | 16.45 Billion | 14.39 Billion | 6.68 Billion | 6.08 Billion |
Cost of Revenue | 3.4 Billion | 11.11 Billion | 8.25 Billion | 2.81 Billion | 742.14 Million |
Gross Profit | 14.24 Billion | 5.33 Billion | 6.14 Billion | 3.87 Billion | 5.33 Billion |
Operating Expenses | 1.57 Billion | 5.66 Billion | 5.82 Billion | 2.9 Billion | 4.57 Billion |
Selling, General and Administrative Expenses | 1.57 Billion | 2.85 Billion | 3.36 Billion | 1.73 Billion | 60.02 Million |
Research and Development Expenses | - | - | - | - | - |
Other Expenses | - | 130.85 Million | 5.32 Million | 17.49 Million | - |
Cost and Expenses | 4.97 Billion | 16.78 Billion | 14.08 Billion | 5.72 Billion | 5.31 Billion |
Operating Income | - | -198.32 Million | 436.35 Million | 1.06 Billion | 914.22 Million |
Interest Expense | 80.91 Million | 92.9 Million | 77.69 Million | 39.29 Million | 44.62 Million |
Income Tax Expense | 332.56 Million | -71.3 Million | 143.58 Million | 301.76 Million | 208.33 Million |
Earnings before Tax | 898.51 Million | -291.23 Million | 374.68 Million | 1.02 Billion | 773.39 Million |
Net Income | 565.95 Million | -219.93 Million | 231.09 Million | 722.91 Million | 565.05 Million |
Earnings Per Share Basic | 5.11 | -1.99 | 2.10 | 10.38 | 8.09 |
Earnings Per Share Diluted | 5.10 | -1.99 | 2.09 | 10.26 | 8.09 |
Weighted Average Shares Outstanding | 110.75 Million | 110.65 Million | 110.12 Million | 69.65 Million | 69.84 Million |
Weighted Average Shares Outstanding (Diluted) | 110.97 Million | 110.65 Million | 110.71 Million | 70.46 Million | 69.82 Million |
Gross Margin | 0.81 | 0.32 | 0.43 | 0.58 | 0.88 |
EBIT Margin | 0.08 | 0.01 | 0.05 | 0.19 | 0.18 |
Profit Margin | 0.03 | -0.01 | 0.02 | 0.11 | 0.09 |
EBITDA | 1.44 Billion | 182.54 Million | 784.02 Million | 1.26 Billion | 1.09 Billion |
Earnings Before Tax Margin | - | -0.01 | 0.03 | 0.16 | 0.15 |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Revenue | 3.85 Billion | 4.97 Billion | 17.65 Billion | 4.46 Billion | 3.74 Billion | 4.46 Billion |
Cost of Revenue | 583.59 Million | 2.7 Billion | 10.52 Billion | 2.59 Billion | 2.41 Billion | 2.8 Billion |
Gross Profit | 3.27 Billion | 2.26 Billion | 7.12 Billion | 1.87 Billion | 1.33 Billion | 1.65 Billion |
Operating Expenses | 3.14 Billion | 1.98 Billion | 6.29 Billion | 1.54 Billion | 1.32 Billion | 1.44 Billion |
Selling, General and Administrative Expenses | 750.77 Million | 930.94 Million | - | 772.94 Million | 630.5 Million | 737.65 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 51.43 Million | 246.47 Million | 355.24 Million | 41.47 Million | 33.28 Million | 34.01 Million |
Cost and Expenses | 3.72 Billion | 4.69 Billion | 16.82 Billion | 4.13 Billion | 3.74 Billion | 4.24 Billion |
Operating Income | 128.25 Million | 525.89 Million | 1.18 Billion | 372.11 Million | 37.41 Million | 247.54 Million |
Interest Expense | 32.25 Million | 20.92 Million | 80.91 Million | 19.25 Million | 23.55 Million | 17.18 Million |
Income Tax Expense | 48.8 Million | 194.17 Million | 332.56 Million | 73.23 Million | -328 Thousand | 65.48 Million |
Earnings before Tax | 147.42 Million | 504.97 Million | 898.51 Million | 198.91 Million | 6.98 Million | 187.64 Million |
Net Income | 98.61 Million | 310.79 Million | 565.95 Million | 125.67 Million | 7.31 Million | 122.16 Million |
Earnings Per Share Basic | 0.89 | 2.80 | - | 1.13 | 0.07 | 1.10 |
Earnings Per Share Diluted | 0.89 | 2.80 | - | 1.13 | 0.07 | 1.10 |
Weighted Average Shares Outstanding | 110.8 Million | 111.05 Million | 110.75 Million | 111.21 Million | 104.48 Million | 111.05 Million |
Weighted Average Shares Outstanding (Diluted) | 110.8 Million | 111.05 Million | 110.97 Million | 111.21 Million | 104.48 Million | 111.05 Million |
Gross Margin | 0.85 | 0.46 | 0.40 | 0.42 | 0.36 | 0.37 |
EBIT Margin | 0.07 | 0.14 | - | 0.11 | 0.04 | 0.08 |
Profit Margin | 0.03 | 0.06 | 0.03 | 0.03 | 0.00 | 0.03 |
EBITDA | 282.53 Million | 696.33 Million | - | 472.91 Million | 138.78 Million | 345.79 Million |
Earnings Before Tax Margin | 0.03 | 0.11 | 0.07 | 0.08 | 0.01 | 0.06 |
301180
SRGXF
001322
PPL-PA
JBCHEPHARM
BASC